ArticleCancer research and treatment2022

Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy.

Aeran Seol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.